A sex-specific group of ten plasma proteins were found to detect 18 different early-stage cancers, representing all major organs of the body, according to a study published in the British Medical Journal Oncology. Researchers said that while cancers of kidney in men and colon in women were easier to detect using their test, bladder cancer in women and thyroid cancer in men were "more challenging but achieved with relatively high accuracy after optimisation". The proteins could also detect liver and ovarian cancers, among others. The research team at Novelna Inc, the US company that designed the test, found that while each of these proteins, by itself, was only moderately accurate at picking up the disease at an early stage, it was highly accurate when combined with other proteins in the group. They said that these proteins were particularly effective at picking up early-stage disease, even as they showed an ability to pick up stage I-III disease and all types of cancer. The team sa
A well-known private healthcare group, Fortis on Friday inaugurated a state-of-the-art facility for the specialised treatment of blood cancers and disorders, which it said "represented a critical step" in addressing the urgent need for comprehensive holistic care. The Fortis Institute of Blood Disorders also integrates paediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, all under one roof, Fortis Healthcare said in a release. The Institute also launched CAR-T cell therapy to its extensive network of Bone Marrow Transplant centres in Mohali, Delhi, Gurgaon, Noida, Mumbai and Bangalore, the statement said. This initiative is supported by a commercial collaboration with ImmunoACT, an IIT-Bombay spin-off and pioneer in India's first fully indigenous and commercially approved gene-modified cell therapy. The NexCAR19, India's first market-authorised CAR-T cell therapy, offers a new ray of hope for treating B-cell lymphomas and B-acute lymphoblast
It helps to enhance the immune function of cancer patients and prevent the side effects of neutropenia caused by chemotherapy
The National Cancer Awareness Day intends to bring issues to light about cancer in addition to encouraging support for research and treatment endeavours dedicated towards handling this deadly disease
In 2022, India recorded around 146,000 cancer cases, and projections indicate that this number is set to rise to 157,000 by 2025
The UK's National Health Service (NHS) will be the first in the world to offer an "under the skin" injection for cancer treatment, possibly decreasing treatment times by up to three quarters
This new method allows cancer patients to receive the immunotherapy drug 'Atezolizumab' through an injection, as opposed to intravenous administration which can take up to an hour
The Minister said, with early diagnosis, and easy access to breakthrough treatments available in the country, India can conquer breast cancer in its early stages itself
The novel super T cells or immune cells were discovered to be more effective against numerous cancer proteins than other killer T cells
Tata Memorial Centre (TMC) is aiming to double its share of cancer patients it serves per year to 20 per cent of the total number of such patients in the country by 2030 from the present 10 per cent, its director Rajendra Badwe said on Friday. Currently, the centre provides treatment to 10 per cent of the country's total cancer patients per year. The premier cancer treatment and research institute, backed by Tata Group and the government, is expanding facilities and educational capabilities to train the manpower, which will be required to achieve the target, Badwe told reporters here. "Presently, India has about 13 lakh cancer patients every year, 10 per cent of those are treated at Tata Hospital. We would like that to be doubled to somewhere about 20 per cent of the total national problem," the director said, adding that the aim to double is being sought to be achieved by the end of the decade. He said the hospital feels there will be a huge increase in the total number of patient
Chief Minister Sukhvinder Singh Sukhu on Monday said a world-class cancer hospital will be set up at Jol Sapper village here, close to the Hamirpur Medical College which is under construction. The chief minister said facilities like robotic surgery will be introduced in the medical college to facilitate the patients. Jol Sapper falls under the Nadaun assembly seat which is represented by Sukhu in the state assembly. Sukhu said that eighteen Rajiv Gandhi day-boarding schools will also be constructed in the state in the next financial year for which land has already been identified, according to an official release. He said the state government has planned to build these schools in each assembly constituency in a phased manner. The schools will be built on more than 100 kanal of land and will provide modern facilities and quality education to the students, he said. Sukhu on Sunday announced that a 100-bed hospital will be built in Sujanpur and said that two denotified institutions
The Apollo Proton Cancer Centre expanded its portfolio with another major addition of Proton Gantry named 'Dr APJ Abdul Kalam Therapy Bay,' in line with the mission to provide the most comprehensive and advanced cancer care in India, the Centre said on Tuesday. Tamil Nadu Minister for Information and Publicity M P Saminathan, and APJMJ Sheik Saleem, co-founder, APJ Abdul Kalam International Foundation, inaugurated the Dr APJ Abdul Kalam Therapy Bay in presence of Harshad Reddy, Director-Operations, Group Oncology & International, Apollo Hospitals, Harish Trivedi, Chief Executive Officer, APCC and Dr Rakesh Jalali, Medical Director & HOD - Radiation Oncology, APCC. The bay comes with a high-tech, most sophisticated and advanced state-of-the-art treatment delivery technique known as image-guided intensity modulated proton therapy (IG-IMPT), a release said. When compared to conventional X-ray-based radiotherapy, this IG-IMPT has minimal to no exposure of normal, healthy organs to
Japanese PM Fumio Kishida announced plans to downgrade the legal status of COVID-19 to the equivalent of seasonal influenza in the spring
Lancet report titled, "Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative," highlights glaring reality
Researchers found that a novel treatment that induces the immune system to eradicate bone marrow cancer cells was effective in as many as 73 per cent of patients in two clinical studies
Cancer screenings and treatment were affected due to Covid but the screening services have gone up post-pandemic, Union Minister of State for Health Bharti Pawar informed Lok Sabha on Friday. Replying to a supplementary question in the Lok Sabha during Question Hour, she said the government is focusing on increasing screenings and early detection of cancer. "Due to Covid, cancer screenings and treatment were affected. After Covid, screenings have increased," Pawar said. She said cancer screening services are being provided through 1.5 lakh Health and Wellness Centres (HWC) across the country. Through these HWCs, 16 crore cases of oral cancer, eight crore cases of breast cancer and around 5.53 crore cases of cervical cancer have been detected, the minister said. "Whether it is rural or urban areas, these services need to be increased. In that view, we are going to increase our 1.5 lakh HWCs throughout the country and through that, we are providing very good screening services," she
Investment activity in the health care space has not slowed down due to the Covid-19 pandemic
Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Cyclophosphamide capsules, used in the treatment of different kinds of cancers, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Hikma Pharmaceuticals USA Inc product, Alembic Pharmaceuticals said in a statement. Cyclophosphamide capsules is an alkylating drug indicated for the treatment of malignant disease and minimal change nephrotic syndrome in pediatric patients. According to IQVIA, cyclophosphamide capsules, 25 mg and 50 mg, have an estimated market size of USD 8 million in the US for twelve months ending Sep 2022. Shares of the drug firm were trading 1.32 per cent down at Rs 630.35 apiece on the BSE.
Pulitzer Prize winner Siddhartha Mukherjee's The Song of The Cell is a beautifully crafted exposition of the author's own lifelong fascination with the subject
Capacity build-up via hub-and-spoke route; experts say country would need 10,000-15,000 more day-care beds and 25,000 surgical beds if all reported patients are to avail treatment